Raymond James Initiates Coverage on REGENXBIO (NASDAQ:RGNX)
Raymond James assumed coverage on shares of REGENXBIO (NASDAQ:RGNX – Free Report) in a research note issued to investors on Friday morning. The firm issued an outperform rating and a $27.00 price target on the biotechnology company’s stock. A number of other analysts have also commented on the company. StockNews.com lowered REGENXBIO from a “hold” […]
Raymond James assumed coverage on shares of REGENXBIO (NASDAQ:RGNX – Free Report) in a research note issued to investors on Friday morning. The firm issued an outperform rating and a $27.00 price target on the biotechnology company’s stock. A number of other analysts have also commented on the company. StockNews.com lowered REGENXBIO from a “hold” […]
-logo-1200x675.png?v=20230222133606&w=240&h=240&zc=2){kind=logo}
